Black Diamond Therapeutics, Inc. (BDTX)

NASDAQ: BDTX · Real-Time Price · USD

2.150

-0.020 (-0.92%)

At close: Mar 19, 2026, 4:00 PM EDT

2.190

+0.040 (1.86%)

After-hours: Mar 19, 2026, 7:33 PM EDT

BDTX Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	70	-	-	-	-
Gross Profit	70	-	-	-	-
Selling, General & Admin	16.57	27.47	27.11	28.39	30.04
Research & Development	33.56	51.31	59.35	64.44	96.83
Other Operating Expenses	7.35	-	-	-	-
Total Operating Expenses	57.48	78.78	86.46	92.83	126.87
Operating Income	12.52	-78.78	-86.46	-92.83	-126.87
Total Non-Operating Income (Expense)	9.85	9.11	4.02	3.91	1.28
Pretax Income	22.37	-69.68	-82.44	-88.92	-125.6
Net Income	22.37	-69.68	-82.44	-91.17	-125.6
Net Income to Common	22.37	-69.68	-82.44	-91.17	-125.6
Shares Outstanding (Basic)	57	55	44	36	36
Shares Outstanding (Diluted)	58	55	44	36	36
Shares Change (YoY)	4.61%	25.19%	21.00%	0.38%	9.97%
EPS (Basic)	0.39	-1.27	-1.88	-2.52	-3.47
EPS (Diluted)	0.39	-1.27	-1.88	-2.52	-3.47
Free Cash Flow	29.61	-62.3	-66.75	-85.27	-102.86
Free Cash Flow Per Share	0.51	-1.13	-1.52	-2.35	-2.84
Gross Margin	100.00%	-	-	-	-
Operating Margin	17.89%	-	-	-	-
Profit Margin	31.95%	-	-	-	-
FCF Margin	42.31%	-	-	-	-
EBITDA	11.57	-82.22	-87.2	-91.78	-124.48
EBITDA Margin	16.53%	-	-	-	-
EBIT	12.52	-78.78	-86.46	-92.83	-126.87
EBIT Margin	17.89%	-	-	-	-

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q